While largely speculative, future studies aimed at more thoroughly documenting longitudinal changes in anatomic, physiologic, and metabolic MRI are warranted to better understand the temporal changes that occur after IDH inhibition in human IDH1-mutant gliomas. This evidence concerns the gene IDH1 and glioma.